NASDAQ:LTRN
Lantern Pharma Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.lanternpharma.comipo date
Jun 11, 2020
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-300 as a combination therapy for no...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus